ImmunityBio’s Stock Sees a Huge Boost - Los Angeles Business Journal

ImmunityBio’s Stock Sees a Huge Boost - Los Angeles Business Journal

Shares of Culver City-based ImmunityBio Inc. surged yet again late last month to nearly a five-year high as its immunotherapy drug Anktiva won approval for marketing in 30 European countries. The rally in the stock price continued for several days with the release of a favorable earnings report. On Feb. 18, the European Commission gave formal approval for Anktiva, which treats certain types of bladder cancer, to be marketed within the 27 member …